Metraipolis › archive › dc_198110aea345

Choice of Antiplatelet vs. Anticoagulant for Blunt Cerebrovascular Injury — Europe PMC PMID:41010306

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41010306
DOI
10.3390/life15091364
License (as archived)
solo-consultazione
Archived
2026-11-10T07:05:28.636Z
SHA-256 of the archived text
80c40f78c964c115291db4cd88686172544e1c914c3452f96ce8538e6595677c
Stable URL of this page
https://metraipolis.com/documento/dc_198110aea345

How to cite

Choice of Antiplatelet vs. Anticoagulant for Blunt Cerebrovascular Injury — Europe PMC PMID:41010306 — Europe PMC (en), https://europepmc.org/article/MED/41010306 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_198110aea345 (Metraipolis archive dc_198110aea345, sha256 80c40f78c964c115291db4cd88686172544e1c914c3452f96ce8538e6595677c)
BibTeX
@misc{dc198110aea345,
  title = {Choice of Antiplatelet vs. Anticoagulant for Blunt Cerebrovascular Injury — Europe PMC PMID:41010306},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41010306},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_198110aea345; sha256 80c40f78c964c115291db4cd88686172544e1c914c3452f96ce8538e6595677c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41010306. Agents can read the archived copy with the MCP tool read_document.